Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M492Revenue $M156Net Margin (%)-45.9Z-Score1.0
Enterprise Value $M451EPS $-1.0Operating Margin %-26.7F-Score3
P/E(ttm))0Cash Flow Per Share $0.7Pre-tax Margin (%)-28.4Higher ROA y-yN
Price/Book1.910-y EBITDA Growth Rate %0Quick Ratio2.7Cash flow > EarningsY
Price/Sales2.85-y EBITDA Growth Rate %0Current Ratio2.8Lower Leverage y-yN
Price/Cash Flow16.2y-y EBITDA Growth Rate %-173.1ROA % (ttm)-16.6Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-28.1Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M65.7ROI % (ttm)5.7Gross Margin Increase y-yY

Gurus Latest Trades with SPPI

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
SPPIJohn Burbank 2012-12-31 Sold Out -0.13%$10.64 - $12.31
($11.39)
$ 7.49-34%Sold Out0
SPPIJoel Greenblatt 2012-12-31 Sold Out -0.02%$10.64 - $12.31
($11.39)
$ 7.49-34%Sold Out0
SPPIJoel Greenblatt 2012-12-31 Sold Out -0.02%$10.64 - $12.31
($11.39)
$ 7.49-34%Sold Out0
SPPIJohn Burbank 2012-09-30 Buy 0.13%$11.6 - $17.05
($13.85)
$ 7.49-46%New holding, 250000 sh.250,000
SPPIJoel Greenblatt 2012-09-30 Buy 0.02%$11.6 - $17.05
($13.85)
$ 7.49-46%New holding, 19901 sh.19,901
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

SPPI is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


SPPI: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
MAIDA ANTHONY E IIIDirector 2013-03-05Sell5,000$11.5-35.65 view
MAIDA ANTHONY E IIIDirector 2013-02-05Sell5,000$12.25-39.59 view
MAIDA ANTHONY E IIIDirector 2013-01-02Sell5,000$11.42-35.2 view
SHROTRIYA RAJESH C MDChairman, CEO & President 2012-12-31Sell378,343$11.29-34.46 view
MAIDA ANTHONY E IIIDirector 2012-12-04Sell5,000$11.65-36.48 view
Keller Joseph KennethEVP & COO 2012-11-12Buy10,000$10.95-32.42 view
MAIDA ANTHONY E IIIDirector 2012-11-01Sell5,000$11.09-33.27 view
SHROTRIYA RAJESH C MDChairman, CEO & President 2012-10-09Sell11,350$12.5-40.8 view
MAIDA ANTHONY E IIIDirector 2012-10-02Sell5,000$11.8-37.29 view
Scott Brett LActing CFO 2012-10-01Sell6,000$12-38.33 view

Press Releases about SPPI :

    Quarterly/Annual Reports about SPPI:

    News about SPPI:

    Articles On GuruFocus.com
    http://seekingalpha. Aug 14 2012 
    Spectrum: Allos Acquisition Means Huge Upside Potential May 04 2012 
    5 Stocks Exceeding Expectations In 2012 Mar 31 2012 
    Was Gilead's Acquisition of Pharmasset a Dose of Bad Medicine? Mar 05 2012 
    Spectrum Pharmaceuticals Inc. Reports Operating Results (10-K) Mar 10 2011 
    Weekly CFO Buys Highlight: CNYD, PRWT, ANCB, SPPI, SPAX Jan 30 2011 
    Weekly CFO Buys Highlight: FUL, SPPI, GRF, BPAX Jan 24 2011 
    Weekly Top Insider Buys: NPBC, FUL, GAM, SHLM, SPPI Jan 23 2011 
    Spectrum Pharmaceuticals Inc. (SPPI) CFO Brett L Scott buys 4,000 Shares Jan 21 2011 
    Spectrum Pharmaceuticals Inc. Reports Operating Results (10-Q) Nov 04 2010 

    More From Other Websites
    Spectrum Pharmaceuticals Out-Licenses Products in China Sep 19 2014
    5 Breakout Stocks Under $10 Set to Soar Higher Sep 18 2014
    Spectrum Pharmaceuticals Out-Licenses Rights for Greater China to CASI Pharmaceuticals for Three of... Sep 18 2014
    Spectrum Pharmaceuticals Out-Licenses Rights for Greater China to CASI Pharmaceuticals for Three of... Sep 18 2014
    Spectrum Pharmaceuticals Out-Licenses Rights for Greater China to CASI Pharmaceuticals for Three of... Sep 18 2014
    Eminem Publishers Sue N.Z. Party: Intellectual Property Sep 16 2014
    Spectrum Pharmaceuticals Announces Issue of a New Patent for Beleodaq™ (belinostat) for Injection... Sep 16 2014
    5 Stocks Under $10 Soaring Higher Sep 12 2014
    Spectrum Pharmaceuticals to Advance Neutropenia Drug Sep 10 2014
    Spectrum Pharmaceuticals Makes Decision to Advance SPI-2012, a Novel Long-Acting GCSF, to Phase 3... Sep 09 2014
    [video] Spectrum CEO: Fusilev Sales Healthy, 'Blockbuster' Announcement Soon Sep 02 2014
    Spectrum Pharmaceuticals to Present Corporate Update at the Morgan Stanley Global Healthcare... Sep 02 2014
    Why Spectrum Fell on Beleodaq Approval but Will Rocket on Melphalan Approval Aug 18 2014
    SPECTRUM PHARMACEUTICALS INC Financials Aug 15 2014
    Spectrum Pharmaceuticals (SPPI) Posts Strong Earnings in Q2 Aug 12 2014
    SPECTRUM PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report Aug 08 2014
    H.C. Wainwright & Co. Sees Significant Upside Ahead For Spectrum Pharmaceuticals Aug 08 2014
    SPECTRUM PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition,... Aug 07 2014
    Spectrum Pharmaceuticals Reports 45% Sales Growth in the Second Quarter, Launches Fifth Product and... Aug 07 2014
    Q2 2014 Spectrum Pharmaceuticals Inc Earnings Release - After Market Close Aug 07 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK